This beat several expectations.
See snapshot below:
§ NPAT of $13.7m, up 292.6% on pcp (OML FY16 est +173.8%).
§ EBITDA of $19.3m was up 302.2% on pcp (OML FY16 est +178.9%).
§ Gross Profit of $43.7m was up 126.4% on pcp (OML FY16 est +121.4%).
§ Gross profit margin of 41.6% was above pcp of 33.1% (OML FY16 est 38.0%).
Stock currently -15%; $11.50